TNF and nosocomial infection: It is of concern that no prior indicator of suboptimal response, such as dose escalation, anti-TNF discontinuation, or augmentation with non-biologic therapy, was reported in these patients, as hospitalization is associated with substantial economic burden and may expose patients to nosocomial infections [15, 16].